163 related articles for article (PubMed ID: 35794782)
1. Bryodulcosigenin attenuates bleomycin-induced pulmonary fibrosis via inhibiting AMPK-mediated mesenchymal epithelial transition and oxidative stress.
Ding Y; Wang L; Liu B; Ren G; Okubo R; Yu J; Zhang C
Phytother Res; 2022 Oct; 36(10):3911-3923. PubMed ID: 35794782
[TBL] [Abstract][Full Text] [Related]
2. Specneuzhenide improves bleomycin-induced pulmonary fibrosis in mice via AMPK-dependent reduction of PD-L1.
Wu Y; Shi W; Li H; Liu C; Shimizu K; Li R; Zhang C
Phytomedicine; 2024 Jun; 128():155318. PubMed ID: 38493719
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen inhalation attenuated bleomycin-induced pulmonary fibrosis by inhibiting transforming growth factor-β1 and relevant oxidative stress and epithelial-to-mesenchymal transition.
Gao L; Jiang D; Geng J; Dong R; Dai H
Exp Physiol; 2019 Dec; 104(12):1942-1951. PubMed ID: 31535412
[TBL] [Abstract][Full Text] [Related]
4. Stevioside attenuates bleomycin-induced pulmonary fibrosis by activating the Nrf2 pathway and inhibiting the NF-κB and TGF-β1/Smad2/3 pathways.
Hao W; Yu TT; Zuo DZ; Hu HZ; Zhou PP
Exp Lung Res; 2023 Nov; 49(1):205-219. PubMed ID: 38044666
[No Abstract] [Full Text] [Related]
5. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
6. Probucol ameliorates EMT and lung fibrosis through restoration of SIRT3 expression.
Zhang HX; Li YN; Wang XL; Ye CL; Zhu XY; Li HP; Yang T; Liu YJ
Pulm Pharmacol Ther; 2019 Aug; 57():101803. PubMed ID: 31085231
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of GHK-Cu in bleomycin-induced pulmonary fibrosis via anti-oxidative stress and anti-inflammation pathways.
Ma WH; Li M; Ma HF; Li W; Liu L; Yin Y; Zhou XM; Hou G
Life Sci; 2020 Jan; 241():117139. PubMed ID: 31809714
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV modulates TGF-β1-dependent epithelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis.
Qian W; Cai X; Qian Q; Zhang W; Wang D
J Cell Mol Med; 2018 Sep; 22(9):4354-4365. PubMed ID: 29971947
[TBL] [Abstract][Full Text] [Related]
9. Mangiferin attenuates bleomycin-induced pulmonary fibrosis in mice through inhibiting TLR4/p65 and TGF-β1/Smad2/3 pathway.
Jia L; Sun P; Gao H; Shen J; Gao Y; Meng C; Fu S; Yao H; Zhang G
J Pharm Pharmacol; 2019 Jun; 71(6):1017-1028. PubMed ID: 30847938
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol ameliorates lipopolysaccharide-induced epithelial mesenchymal transition and pulmonary fibrosis through suppression of oxidative stress and transforming growth factor-β1 signaling.
Zhang YQ; Liu YJ; Mao YF; Dong WW; Zhu XY; Jiang L
Clin Nutr; 2015 Aug; 34(4):752-60. PubMed ID: 25234611
[TBL] [Abstract][Full Text] [Related]
11. Protective effects of heterophyllin B against bleomycin-induced pulmonary fibrosis in mice via AMPK activation.
Shi W; Hao J; Wu Y; Liu C; Shimizu K; Li R; Zhang C
Eur J Pharmacol; 2022 Apr; 921():174825. PubMed ID: 35283110
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells.
Duan JX; Guan XX; Yang HH; Mei WX; Chen P; Tao JH; Li Q; Zhou Y
Int Immunopharmacol; 2021 Dec; 101(Pt B):108211. PubMed ID: 34634687
[TBL] [Abstract][Full Text] [Related]
13. Salvia miltiorrhiza Bunge extract and Przewalskin ameliorate Bleomycin-induced pulmonary fibrosis by inhibition of apoptosis, oxidative stress and collagen deposition via the TGF-β1 pathway.
Zeng M; Feng A; Ren Y; Zhang Q; Wang R; Zhang B; Liu M; Guo P; Zhang Y; Lyu J; Zheng X
Phytomedicine; 2024 Mar; 125():155339. PubMed ID: 38237513
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency exacerbates bleomycin-induced pulmonary fibrosis partially through aggravating TGF-β/Smad2/3-mediated epithelial-mesenchymal transition.
Li SR; Tan ZX; Chen YH; Hu B; Zhang C; Wang H; Zhao H; Xu DX
Respir Res; 2019 Nov; 20(1):266. PubMed ID: 31775746
[TBL] [Abstract][Full Text] [Related]
15. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition.
Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T
J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951
[TBL] [Abstract][Full Text] [Related]
16. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
17. Modulation of bleomycin-induced oxidative stress and pulmonary fibrosis by N-acetylcysteine in rats via AMPK/SIRT1/NF-κβ.
Mansour HH; Omran MM; Hasan HF; El Kiki SM
Clin Exp Pharmacol Physiol; 2020 Dec; 47(12):1943-1952. PubMed ID: 32658336
[TBL] [Abstract][Full Text] [Related]
18. S-allylmercapto-N-acetylcysteine ameliorates pulmonary fibrosis in mice via Nrf2 pathway activation and NF-κB, TGF-β1/Smad2/3 pathway suppression.
Zhang Q; Ye W; Liu Y; Niu D; Zhao X; Li G; Qu Y; Zhao Z
Biomed Pharmacother; 2023 Jan; 157():114018. PubMed ID: 36410121
[TBL] [Abstract][Full Text] [Related]
19. Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis.
Ding D; Shen X; Yu L; Zheng Y; Liu Y; Wang W; Liu L; Zhao Z; Nian S; Liu L
Phytother Res; 2023 Jul; 37(7):2787-2799. PubMed ID: 36807664
[TBL] [Abstract][Full Text] [Related]
20. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition.
Lu GX; Bian DF; Ji Y; Guo JM; Wei ZF; Jiang SD; Xia YF; Dai Y
Phytother Res; 2014 Aug; 28(8):1224-31. PubMed ID: 24458872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
